Retina

Research reveals how neighborhood social factors impact patients with tractional retinal detachments, highlighting the need for improved access to care and support.

Reliable visualization tools, especially those indicated for ocular use, are crucial for success.

Patients weigh in on the value of provider communication.

Neurotech Pharmaceuticals performs the first ENCELTO procedure.

Franklin shares how methotrexate significantly reduces reoperation rates in diabetic patients with retinal detachments, enhancing postoperative outcomes and vision.

Matthew Starr, MD, discusses techniques for correcting astigmatism in patients lacking capsular support, enhancing visual outcomes surgery.

Christina Weng, MD, MBA, FASRS, explores the viability of postoperative day 0 exams as a substitute for day 1 after vitreoretinal surgery, revealing promising findings.

Topcon Healthcare enhances its connected care model by acquiring IRIS, integrating AI for improved diabetic eye disease screening and patient coordination.

The platform, developed by University College London and Heidelberg Engineering, demonstrated accuracy and precision in early tests.

RetinalGeniX partners with Labcorp to enhance genetic testing and retinal imaging, aiming for early disease detection and improved patient care.

How artificial intelligence could enhance clinical trials.

Patients express mixed feelings about AI in healthcare, favoring its use for documentation and administrative tasks while demanding transparency and safety standards.

Insights on injection technique and the future potential of SCS treatments.

Looking at innovative tools and their applications in different disease states can help to think creatively about ways to benefit patients in retina care.

The LYNX LIO is the latest generation of pattern scanning lasers that were first introduced in 2006.

This partnership aims to address care gaps by identifying untreated and undertreated patients at scale.

Machine learning algorithms enhance retinopathy of prematurity screening using smartphone images, expanding access in low-resource settings and easing pediatric ophthalmologist workloads.

Topcon Healthcare launches IDHea, an innovative platform enhancing AI research and ocular data access to improve clinical outcomes in healthcare.

KIO-104 is a therapeutic candidate shown to significantly reduce retinal scar formation.

Novel color created, olo, beyond previous human perception.

PYK-2101 is a focal hydrogel retinal sealant for use in patients undergoing surgery for a detached retina.